Physician profile
Bimal Patel
NPI 1578855045
$672.26
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $85.26 · 2022: $116 · 2023: $154 · 2024: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $235.39 | 2023-2024 | Vabomere, Rezzayo |
| Paratek Pharmaceuticals, INC. | $100.35 | 2022 | |
| Pfizer INC. | $37.72 | 2019 | |
| Abbvie INC. | $37.52 | 2019-2020 | |
| Avion Pharmaceuticals | $30.19 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $28.84 | 2023 | Exparel |
| Lupin INC. | $28.56 | 2019-2020 | |
| Hologic Sales and Service, LLC | $20.87 | 2019 | |
| Biom'Up France Sas | $20.83 | 2020 | |
| Smith+Nephew, INC. | $20.00 | 2019 | |
| Biom'Up Sa | $17.89 | 2019 | |
| Allergan, INC. | $17.71 | 2019 | |
| Therapeuticsmd, INC. | $17.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.08 | 2019 | |
| Organon LLC | $15.98 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $14.23 | 2019 | |
| Merck Sharp & Dohme LLC | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bimal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.